Roche Holding AG
RO
Rangering i aksjer
#44
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Aksjekurs
$500.46
Sist synkronisert: 2026-10-19
Markedsverdi
$340.50B
Endring (1 dag)
0.05%
Endring (1 år)
34.35%
Land
CH
Handel Roche Holding AG (RO)
Kategori
Healthcare
Utbyttehistorikk for Roche Holding AG (RO)
Roche Holding AG (aksjesymbol: RO) har gitt totalt 33 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): $160.40
Utbytteavkastning (TTM): 0.0269
Summen av alle utbytter (justert for aksjesplitt): $160.40
Utbytteavkastning (TTM): 0.0269
Utbyttebetalinger for Roche Holding AG (RO) fra 1995 til 2026
Årlige utbyttebetalinger
| År | Utbytte (justert for aksjesplitt) | Endre |
|---|---|---|
| 2026 (TTM) | $9.70 | 0.00% |
| 2025 | $9.70 | 1.04% |
| 2024 | $9.60 | 1.05% |
| 2023 | $9.50 | 2.15% |
| 2022 | $9.30 | 2.20% |
| 2021 | $9.10 | 1.11% |
| 2020 | $9.00 | 3.45% |
| 2019 | $8.70 | 4.82% |
| 2018 | $8.30 | 1.22% |
| 2017 | $8.20 | 1.23% |
| 2016 | $8.10 | 1.25% |
| 2015 | $8.00 | 2.56% |
| 2014 | $7.80 | 6.12% |
| 2013 | $7.35 | 8.09% |
| 2012 | $6.80 | 3.03% |
| 2011 | $6.60 | 10.00% |
| 2010 | $6.00 | 20.00% |
| 2009 | $5.00 | 8.70% |
| 2008 | $4.60 | 35.29% |
| 2007 | $3.40 | 23.64% |
| 2006 | $2.75 | 14.11% |
| 2005 | $2.41 | 46.06% |
| 2004 | $1.65 | 13.79% |
| 2003 | $1.45 | 11.54% |
| 2002 | $1.30 | 13.04% |
| 2001 | $1.15 | 15.00% |
| 2000 | $1.00 | 14.94% |
| 1999 | $0.87 | 4.82% |
| 1998 | $0.83 | 10.67% |
| 1997 | $0.75 | 17.19% |
| 1996 | $0.64 | 16.36% |
| 1995 | $0.55 | 0.00% |
Liste over alle utbyttebetalinger
| År | Utbytte | Endre |
|---|---|---|
| 2026 (TTM) | $9.70 | 0.00% |
| 2025 | $9.70 | 1.04% |
| 2024 | $9.60 | 1.05% |
| 2023 | $9.50 | 2.15% |
| 2022 | $9.30 | 2.20% |
| 2021 | $9.10 | 1.11% |
| 2020 | $9.00 | 3.45% |
| 2019 | $8.70 | 4.82% |
| 2018 | $8.30 | 1.22% |
| 2017 | $8.20 | 1.23% |
| 2016 | $8.10 | 1.25% |
| 2015 | $8.00 | 2.56% |
| 2014 | $7.80 | 6.12% |
| 2013 | $7.35 | 8.09% |
| 2012 | $6.80 | -98.97% |
| 2011 | $660.00 | 10.00% |
| 2010 | $600.00 | 20.00% |
| 2009 | $500.00 | 8.70% |
| 2008 | $460.00 | 35.29% |
| 2007 | $340.00 | 23.64% |
| 2006 | $275.00 | 14.11% |
| 2005 | $241.00 | 46.06% |
| 2004 | $165.00 | 13.79% |
| 2003 | $145.00 | 11.54% |
| 2002 | $130.00 | -98.87% |
| 2001 | $11,500.00 | 15.00% |
| 2000 | $10,000.00 | 14.94% |
| 1999 | $8,700.00 | 4.82% |
| 1998 | $8,300.00 | 10.67% |
| 1997 | $7,500.00 | 17.19% |
| 1996 | $6,400.00 | 16.36% |
| 1995 | $5,500.00 | 0.00% |
Utbyttebetalinger for lignende selskaper eller konkurrenter
| Selskap | Antall utbyttebetalinger | Land |
|---|---|---|
| 215.00% |
US
|
|
| 225.00% |
US
|
|
| 53.00% |
US
|
|
| 223.00% |
US
|
|
| 29.00% |
CH
|
